ArticleJournal of translational medicine2009
Evolutionary concepts in biobanking - the BC BioLibrary.
Article in Journal of translational medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.
- Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review.Einstein (Sao Paulo, Brazil) · 2021Pooled it
- Impact of non-welfare interests on willingness to donate to biobanks: an experimental survey.Journal of empirical research on human research ethics : JERHRE · 2014Trial
- Institutional Biobanking as shared public health infrastructure: a financially sustainable service center model.Frontiers in health services · 2026Article
- Review
- Review
- A scoping review of considerations and practices for benefit sharing in biobanking.BMC medical ethics · 2021Article
- Effects of ex vivo ischemia time and delayed processing on quality of specimens in tissue biobank.Molecular medicine reports · 2020Article
- Biobanking for Cancer Biomarker Research: Issues and Solutions.Biomarker insights · 2020Review
- If you build it, they will come: unintended future uses of organised health data collections.BMC medical ethics · 2016Review
- Development of an Integrated Biospecimen Database among the Regional Biobanks in Korea.Healthcare informatics research · 2016Article
- A framework for biobank sustainability.Biopreservation and biobanking · 2014Article
- Linkage of data from diverse data sources (LDS): a data combination model provides clinical data of corresponding specimens in biobanking information system.Journal of medical systems · 2013Article
- Public perspectives on biospecimen procurement: what biorepositories should consider.Biopreservation and biobanking · 2013Article
- Co-occurrence of anaerobic bacteria in colorectal carcinomas.Microbiome · 2013Article
- Active choice but not too active: public perspectives on biobank consent models.Genetics in medicine : official journal of the American College of Medical Genetics · 2011Article
- Leveraging a clinical research information system to assist biospecimen data and workflow management: a hybrid approach.Journal of clinical bioinformatics · 2011Article
- Translational Medicine is developing in China: a new venue for collaboration.Journal of translational medicine · 2011Article
- Biobanks: importance, implications and opportunities for genetic counselors.Journal of genetic counseling · 2010Review
- Of mice and men: the evolution of animal welfare guidelines for cancer research.British journal of cancer · 2010Article
- Structuring public engagement for effective input in policy development on human tissue biobanking.Public health genomics · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedical research to improve health care faces a major problem in the relatively limited availability of adequately annotated and collected biospecimens. This limitation is creating a growing gap between the pace of scientific advances and successful exploitation of this knowledge. Biobanks are an important conduit for transfer of biospecimens (tissues, blood, body fluids) and related health data to research. They have evolved outside of the historical source of tissue biospecimens, clinical pathology archives. Research biobanks have developed advanced standards, protocols, databases, and mechanisms to interface with researchers seeking biospecimens. However, biobanks are often limited in their capacity and ability to ensure quality in the face of increasing demand. Our strategy to enhance both capacity and quality in research biobanking is to create a new framework that repatriates the activity of biospecimen accrual for biobanks to clinical pathology.
methodsThe British Columbia (BC) BioLibrary is a framework to maximize the accrual of high-quality, annotated biospecimens into biobanks. The BC BioLibrary design primarily encompasses: 1) specialized biospecimen collection units embedded within clinical pathology and linked to a biospecimen distribution system that serves biobanks; 2) a systematic process to connect potential donors with biobanks, and to connect biobanks with consented biospecimens; and 3) interdisciplinary governance and oversight informed by public opinion.
resultsThe BC BioLibrary has been embraced by biobanking leaders and translational researchers throughout BC, across multiple health authorities, institutions, and disciplines. An initial pilot network of three Biospecimen Collection Units has been successfully established. In addition, two public deliberation events have been held to obtain input from the public on the BioLibrary and on issues including consent, collection of biospecimens and governance.
conclusionThe BC BioLibrary framework addresses common issues for clinical pathology, biobanking, and translational research across multiple institutions and clinical and research domains. We anticipate that our framework will lead to enhanced biospecimen accrual capacity and quality, reduced competition between biobanks, and a transparent process for donors that enhances public trust in biobanking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.